1-3 of 3
Agne Taraseviciute
Close
Sort by
Journal Articles

Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells

Adam J. Lamble, Regina M. Myers, Agne Taraseviciute, Samuel John, Bonnie Yates, Seth M. Steinberg, Jennifer Sheppard, Alexandra E. Kovach, Brent Wood, Michael J. Borowitz, Maryalice Stetler-Stevenson, Constance M. Yuan, Vinodh Pillai, Toni Foley, Perry Chung, Lee Chen, Daniel W. Lee, Colleen Annesley, Amanda DiNofia, Stephan A. Grupp, Michael R. Verneris, Lia Gore, Theodore W. Laetsch, Deepa Bhojwani, Patrick A. Brown, Michael A. Pulsipher, Susan R. Rheingold, Rebecca A. Gardner, Nirali N. Shah
Journal: Blood Advances
Blood Adv (2023) 7 (4): 575–585.
https://doi.org/10.1182/bloodadvances.2022007423
Published: 2023
Includes: Supplemental data
Journal Articles

Low rate of subsequent malignant neoplasms after CD19 CAR T-cell therapy

Emily M. Hsieh, Regina M. Myers, Bonnie Yates, Colleen Annesley, Samuel John, Agne Taraseviciute, Seth M. Steinberg, Jennifer Sheppard, Perry Chung, Lee Chen, Daniel W. Lee, Amanda DiNofia, Stephan A. Grupp, Michael R. Verneris, Theodore W. Laetsch, Deepa Bhojwani, Patrick A. Brown, Michael A. Pulsipher, Susan R. Rheingold, Rebecca A. Gardner, Lia Gore, Nirali N. Shah, Adam J. Lamble
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5222–5226.
https://doi.org/10.1182/bloodadvances.2022008093
Published: 2022
Journal Articles

Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype

Clinical Trials & Observations
Jay Sarthy, Ji Zha, Daria Babushok, Archana Shenoy, Jian-Meng Fan, Gerald Wertheim, Adam Himebauch, Ashley Munchel, Agne Taraseviciute, Samuel Yang, Hirohito Shima, Satoshi Narumi, Soheil Meshinchi, Timothy S. Olson
Journal: Blood Advances
Blood Adv (2018) 2 (2): 120–125.
https://doi.org/10.1182/bloodadvances.2017012682
Published: 2018
Includes: Supplemental data